BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37639006)

  • 1. Establishment and validation of a competitive risk model for predicting cancer-specific survival in patients with osteosarcoma: a population-based study.
    Wu X; Wang J; He D
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15383-15394. PubMed ID: 37639006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
    Shao Z; Li J; Liu Z; Bi S
    Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
    Yu Y; Wang S; Liu J; Ge J; Guan H
    Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis.
    Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
    Front Public Health; 2022; 10():837506. PubMed ID: 35178367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.
    Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
    Front Public Health; 2022; 10():840525. PubMed ID: 35273943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
    Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
    Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and Validation of Nomograms for Predicting the Prognosis of Juvenile Osteosarcoma: A Real-World Analysis in the SEER Database.
    Jiang Y; Wang T; Wei Z
    Technol Cancer Res Treat; 2020; 19():1533033820947718. PubMed ID: 33054584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
    Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
    Front Public Health; 2022; 10():946299. PubMed ID: 36159305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an online prognostic nomogram for osteosarcoma after surgery: a retrospective study based on the SEER database and external validation with single-center data.
    Feng L; Chen Y; Ye T; Shao Z; Ye C; Chen J
    Transl Cancer Res; 2022 Sep; 11(9):3156-3174. PubMed ID: 36237232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prognostic factors of adult patients with osteosarcoma from the SEER database.
    Deng G; Chen P
    Medicine (Baltimore); 2023 Sep; 102(37):e33653. PubMed ID: 37713904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.
    Liu Z; Li G; Liu H; Zhu J; Wang D
    Int J Clin Pract; 2022; 2022():8568724. PubMed ID: 36380749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients Undergoing Surgery With Prostate Cancer: A Population-Based Study.
    Zhang Z; Zhanghuang C; Wang J; Mi T; Liu J; Tian X; Jin L; He D
    Front Public Health; 2022; 10():935521. PubMed ID: 35903379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database.
    Wang J; Tang J; Liu X; He D
    BMC Urol; 2022 May; 22(1):78. PubMed ID: 35610606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
    Jiao S; Guo L; Da F; Gao Q; Ren Z; Wang J; Fu Q; Liu J
    Technol Cancer Res Treat; 2023; 22():15330338231164191. PubMed ID: 37078156
    [No Abstract]   [Full Text] [Related]  

  • 17. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
    Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
    Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.